Please Wait.....
Report
Cartilage Repair/Cartilage Regeneration Market by Treatment Modalities (Cell-Based (Chondrocyte Transplantation, Stem Cells, Growth Factors), Non-Cell (Tissue Scaffolds)), Application (Hyaline, Fibrocartilage), Site, and Region - Global Forecast to 2028
Market Report I 2023-12-15 I 155 Pages I MarketsandMarkets
The global Cartilage Repair/Cartilage Regeneration Market is projected to reach USD 2.8 Billion by 2028 from USD 1.3 Billion in 2023, at a CAGR of 17.2% during the forecast period. Cell-based procedures like chondrocyte transplantation, growth factors, and stem cells are mainly driven by the, rising number of cartilage repair procedures and the increasing number of osteoarthritis cases which is expected to drive the cell-based research and advancement in a number of hospitals in upcoming years.
"The hyaline cartilage segment accounted for the highest market share in the application segment market, by application, during the forecast period."
Based on the application of the segment, the Cartilage Repair/Cartilage Regeneration Market market is categorized into hyaline cartilage and fibrocartilage. Hyaline cartilage is expected to have the highest growth in the market, which is attributed to the availability of the funding and the rising investment in R&D and increasing growth opportunities in emerging economies will drive the hyaline cartilage market.
"The North America segment accounted for the highest market share in Cartilage Repair/Cartilage Regeneration Market Cartilage Repair/Cartilage Regeneration Market, by region, during the forecast period."
Based on the region, the Cartilage Repair/Cartilage Regeneration Market is divided into North America, Europe, Asia Pacific, and Rest of the world. In 2022, North America had the highest market as the key players for the cartilage repair market mainly have the presence in countries like US and Canada and the growing number of knee replacement surgeries and the use of cartilage repair products for the treatment of cartilage damage or injury.
Breakdown of supply-side primary interviews by company type, designation, and region:
- By Company Type: Tier 1 (30%), Tier 2 (44%), and Tier 3 (26%)
- By Designation: C-level (30%), Director-level (33%), and Others (37%)
- By Region: North America (40%), Europe (28%), Asia-Pacific (18%), RoW- (14%),
Prominent companies include Smith+Nephew (UK), DePuy Synthes (Johnson & Johnson) (US), Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Vericel Corporation (US), B. Braun Melsungen AG (US), Anika Therapeutics (US), CONMED Corporation (US), MEDIPOST (South Korea), RTI Surgical (US), Arthrex, Inc. (US), Regrow Biosciences (India), Geistlich Pharma AG (Switzerland), AlloSource (US), Orthocell Ltd, (Australia), Matricel GmbH (Germany), CartiHeal, Inc. (Israel), Regentis Biomaterials (Israel), Theracell Advanced Biotechnology (Greece) and LifeNet Health (US).
Research Coverage
This research report categorizes the Cartilage Repair/Cartilage Regeneration Market which is segmented into products used for Cartilage Repair/Cartilage Regeneration and the application and site of application.
The treatment modality for Cartilage Repair/Cartilage Regeneration is divided into two types: cell-based, i.e., chondrocyte transplantation, growth factors, and stem cells and non-cell-based, i.e., tissue scaffolds and cell-free composites. The Application segments the classised into hyaline cartilage and fibrocartilage. The application site segment is classified as knee, hip, ankle & foot, and other application sites (nose and shoulder), and regional segment is divided into the North America, Europe, Asia Pacific and the Rest of the world. The scope of the report covers detailed information regarding the major factors like market dynamics such as drivers, restraints, challenges, and opportunities that are influencing the growth of the Cartilage Repair/Cartilage Regeneration Market.
A detailed analysis of the key industry players also the companies new launches, developments, mergers and acquisitions associated with the Cartilage Repair/Cartilage Regeneration Market has been covered. Competitive analysis of upcoming startups in the Cartilage Repair/Cartilage Regeneration Market ecosystem is covered in this report.
Key Benefits of Buying the Report:
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Cartilage Repair/Cartilage Regeneration Market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
The report provides insights on the following pointers:
- Analysis of key drivers (Increasing incidence of osteoarthritis, Increasing research funding and investments and Rising number of sports and accident-related orthopedic injuries), restraints (High cost of cartilage repair surgeries and Unfavorable reimbursement scenario) opportunities (Technological advancements in the cartilage repair market and Development in the field of regenerative medicine and Challenges (Limitation of cartilage-based stem cell products and Need for skill personnel) are influencing the growth of the Cartilage Repair/Cartilage Regeneration Market.
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Cartilage Repair/Cartilage Regeneration Market.
- Market Development: Comprehensive information about lucrative markets - the report analyses the Cartilage Repair/Cartilage Regeneration Market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the Cartilage Repair/Cartilage Regeneration Market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, among others, in the Cartilage Repair/Cartilage Regeneration Market strategies.
1 INTRODUCTION 23
1.1 STUDY OBJECTIVES 23
1.2 MARKET DEFINITION 23
TABLE 1 INCLUSIONS AND EXCLUSIONS 23
1.3 MARKET SCOPE 24
1.3.1 MARKETS COVERED 24
1.3.2 YEARS CONSIDERED 24
1.3.3 CURRENCY CONSIDERED 25
1.4 STAKEHOLDERS 25
1.5 SUMMARY OF CHANGES 25
1.5.1 RECESSION IMPACT 25
2 RESEARCH METHODOLOGY 26
2.1 RESEARCH DATA 26
FIGURE 1 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: RESEARCH DESIGN 26
2.1.1 SECONDARY DATA 27
2.1.1.1 Secondary sources 27
2.1.2 PRIMARY DATA 28
FIGURE 2 PRIMARY SOURCES 28
2.1.2.1 Key data from primary sources 29
2.1.2.2 Key industry insights 30
2.1.2.3 Breakdown of primary interviews 30
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 30
2.2 MARKET SIZE ESTIMATION 31
2.2.1 APPROACH 1: COMPANY REVENUE ESTIMATION APPROACH 31
FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION 31
2.2.2 APPROACH 2: CALCULATING MARKET SIZE FROM NUMBER OF CARTILAGE REPAIR TREATMENT PROCEDURES 32
TABLE 2 REVENUE ESTIMATION APPROACH BY CALCULATING NUMBER OF CARTILAGE REPAIR TREATMENTS PROCEDURES IN US 32
2.2.3 APPROACH 3: CORPORATE PRESENTATIONS OF COMPANIES AND PRIMARY INTERVIEWS 32
2.2.4 APPROACH 4: PRIMARY INTERVIEWS 32
2.2.5 APPROACH 5: FINAL MARKET CALCULATION 33
FIGURE 5 GROWTH FORECAST 33
FIGURE 6 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 33
FIGURE 7 TOP-DOWN APPROACH 34
?
2.3 MARKET BREAKDOWN & DATA TRIANGULATION 34
FIGURE 8 DATA TRIANGULATION METHODOLOGY 35
2.4 MARKET SHARE ANALYSIS 36
2.5 MARKET ASSUMPTIONS 36
2.6 RISK ASSESSMENT 36
2.7 LIMITATIONS 37
2.8 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: RECESSION IMPACT ANALYSIS 37
3 EXECUTIVE SUMMARY 38
FIGURE 9 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2023 VS. 2028 (USD MILLION) 38
FIGURE 10 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION) 39
FIGURE 11 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2023 VS. 2028 (USD MILLION) 39
FIGURE 12 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: GEOGRAPHIC SNAPSHOT 40
4 PREMIUM INSIGHTS 41
4.1 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET OVERVIEW 41
FIGURE 13 INCREASING INCIDENCE OF OSTEOARTHRITIS TO DRIVE MARKET 41
4.2 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION AND COUNTRY, 2022 42
FIGURE 14 HYALINE CARTILAGE HELD LARGEST SHARE IN 2022 42
4.3 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 42
FIGURE 15 JAPAN TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 42
5 MARKET OVERVIEW 43
5.1 INTRODUCTION 43
5.2 MARKET DYNAMICS 43
FIGURE 16 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 43
5.2.1 MARKET DRIVERS 44
5.2.1.1 Increasing incidence of osteoarthritis 44
5.2.1.2 Increasing research funding and investments 44
5.2.1.3 Rising number of sports and accident-related orthopedic injuries 45
5.2.2 RESTRAINTS 45
5.2.2.1 High cost of cartilage repair surgeries 45
5.2.2.2 Unfavorable reimbursement scenario 45
5.2.3 OPPORTUNITIES 46
5.2.3.1 Technological advancements 46
5.2.3.2 Developments in regenerative medicine 46
5.2.4 CHALLENGES 47
5.2.4.1 Limitations of cartilage-based stem cell products 47
5.2.4.2 Need for skilled personnel 47
5.3 SUPPLY CHAIN ANALYSIS 48
FIGURE 17 DISTRIBUTION-KEY STRATEGY PREFERRED BY PROMINENT COMPANIES 48
5.4 REGULATORY LANDSCAPE 49
5.4.1 INTRODUCTION 49
5.4.2 NORTH AMERICA 49
TABLE 3 CLASSIFICATION BASED ON SUBMISSION REQUIRED FOR REGULATORY APPROVAL 49
5.4.3 EUROPE 50
5.4.4 ASIA PACIFIC 50
5.5 PATENT ANALYSIS 52
FIGURE 18 PATENT ANALYSIS FOR CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET 52
5.6 PIPELINE ANALYSIS 53
5.6.1 PIPELINE ANALYSIS, BY CLINICAL TRIAL PHASE 53
FIGURE 19 CARTILAGE REPAIR CANDIDATE PRODUCTS IN CLINICAL PHASES ONE TO FOUR 53
TABLE 4 INDICATIVE LIST OF CANDIDATES IN CLINICAL TRIALS 53
5.7 TECHNOLOGY ANALYSIS 54
6 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY 55
6.1 INTRODUCTION 56
TABLE 5 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 56
6.2 CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION 56
TABLE 6 CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 56
TABLE 7 CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION) 57
TABLE 8 NORTH AMERICA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 57
TABLE 9 EUROPE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 57
TABLE 10 ASIA PACIFIC: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 58
6.2.1 CHONDROCYTE TRANSPLANTATION 58
6.2.1.1 Cost-effectiveness to support market growth 58
TABLE 11 CHONDROCYTE TRANSPLANTATION MARKET, BY REGION, 2021-2028 (USD MILLION) 59
TABLE 12 NORTH AMERICA: CHONDROCYTE TRANSPLANTATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 59
6.2.2 GROWTH FACTORS 59
6.2.2.1 Promising results associated with growth factors to drive market 59
TABLE 13 GROWTH FACTORS MARKET, BY REGION, 2021-2028 (USD MILLION) 59
TABLE 14 NORTH AMERICA: GROWTH FACTORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 60
6.2.3 STEM CELLS 60
6.2.3.1 Advancements in stem cell-based tissue engineering to support market growth 60
TABLE 15 STEM CELLS MARKET, BY REGION, 2021-2028 (USD MILLION) 60
TABLE 16 NORTH AMERICA: STEM CELLS MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 61
6.3 NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION 61
TABLE 17 NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 61
TABLE 18 NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION) 61
TABLE 19 NORTH AMERICA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 62
TABLE 20 EUROPE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 62
TABLE 21 ASIA PACIFIC: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 62
6.3.1 TISSUE SCAFFOLDS 63
6.3.1.1 Benefits of one-step procedure likely to boost market growth 63
TABLE 22 TISSUE SCAFFOLDS MARKET, BY REGION, 2021-2028 (USD MILLION) 63
6.3.2 CELL-FREE COMPOSITES 63
6.3.2.1 Increasing research to support market growth 63
TABLE 23 CELL-FREE COMPOSITES MARKET, BY REGION, 2021-2028 (USD MILLION) 64
7 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET,
BY APPLICATION SITE 65
7.1 INTRODUCTION 66
TABLE 24 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 66
7.2 KNEE 66
7.2.1 INCREASING CASES OF KNEE ARTHROSCOPY TO DRIVE MARKET GROWTH 66
TABLE 25 KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION) 67
TABLE 26 NORTH AMERICA: KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 67
TABLE 27 EUROPE: KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 67
TABLE 28 ASIA PACIFIC: KNEE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 68
7.3 HIP 68
7.3.1 INCREASING ADOPTION OF MINIMALLY INVASIVE ARTHROSCOPY PROCEDURES TO SUPPORT MARKET GROWTH 68
TABLE 29 HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION) 68
TABLE 30 NORTH AMERICA: HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 69
TABLE 31 EUROPE: HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 69
TABLE 32 ASIA PACIFIC: HIP CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 69
7.4 ANKLE & FOOT 70
7.4.1 INCREASING SPORTS INJURIES TO DRIVE DEMAND 70
TABLE 33 ANKLE & FOOT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION) 70
TABLE 34 NORTH AMERICA: ANKLE & FOOT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 70
TABLE 35 EUROPE: ANKLE & FOOT CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 71
7.5 OTHER APPLICATION SITES 71
TABLE 36 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET FOR OTHER APPLICATION SITES, BY REGION, 2021-2028 (USD MILLION) 71
TABLE 37 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET FOR OTHER APPLICATION SITES, BY COUNTRY, 2021-2028 (USD MILLION) 72
8 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION 73
8.1 INTRODUCTION 74
TABLE 38 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 74
8.2 HYALINE CARTILAGE 74
8.2.1 HYALINE CARTILAGE SEGMENT TO HOLD LARGER MARKET SHARE 74
TABLE 39 HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION) 75
TABLE 40 NORTH AMERICA: HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 75
TABLE 41 EUROPE: HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 75
TABLE 42 ASIA PACIFIC: HYALINE CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 76
8.3 FIBROCARTILAGE 76
8.3.1 SUPPORT AND STRENGTH ADVANTAGES FOR SURROUNDING STRUCTURES TO DRIVE MARKET 76
TABLE 43 FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION) 76
TABLE 44 NORTH AMERICA: FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 77
TABLE 45 EUROPE: FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 77
TABLE 46 ASIA PACIFIC: FIBROCARTILAGE REPAIR/REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 77
9 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION 78
9.1 INTRODUCTION 79
TABLE 47 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY REGION, 2021-2028 (USD MILLION) 79
9.2 NORTH AMERICA 79
9.2.1 NORTH AMERICA: RECESSION IMPACT 79
FIGURE 20 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET SNAPSHOT 80
TABLE 48 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 81
TABLE 49 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 81
TABLE 50 NORTH AMERICA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 81
TABLE 51 NORTH AMERICA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 82
TABLE 52 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 82
TABLE 53 NORTH AMERICA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 82
9.2.2 US 83
9.2.2.1 Increasing incidence of osteoporosis to drive market 83
TABLE 54 US: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 83
TABLE 55 US: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 83
TABLE 56 US: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 84
TABLE 57 US: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 84
TABLE 58 US: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 84
9.2.3 CANADA 85
9.2.3.1 Increasing investments in regenerative medicine research to drive market 85
TABLE 59 CANADA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 85
TABLE 60 CANADA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 85
TABLE 61 CANADA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 86
TABLE 62 CANADA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 86
TABLE 63 CANADA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 86
?
9.3 EUROPE 87
9.3.1 EUROPE: RECESSION IMPACT 87
TABLE 64 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 87
TABLE 65 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 88
TABLE 66 EUROPE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 88
TABLE 67 EUROPE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 88
TABLE 68 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 89
TABLE 69 EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 89
9.3.2 GERMANY 89
9.3.2.1 Strong R&D base and focus on minimally invasive surgeries to support market growth 89
TABLE 70 GERMANY: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 90
TABLE 71 GERMANY: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 90
TABLE 72 GERMANY: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 90
TABLE 73 GERMANY: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 91
TABLE 74 GERMANY: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 91
9.3.3 UK 91
9.3.3.1 Rising prevalence of joint diseases to boost demand 91
TABLE 75 UK: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 92
TABLE 76 UK: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 92
TABLE 77 UK: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 92
TABLE 78 UK: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 93
TABLE 79 UK: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 93
9.3.4 FRANCE 93
9.3.4.1 Rising degenerative disease and healthcare expenditure to drive market 93
TABLE 80 FRANCE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 94
TABLE 81 FRANCE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 94
TABLE 82 FRANCE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 94
TABLE 83 FRANCE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 95
TABLE 84 FRANCE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 95
9.3.5 REST OF EUROPE 95
TABLE 85 REST OF EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 96
TABLE 86 REST OF EUROPE: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 96
TABLE 87 REST OF EUROPE: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 96
TABLE 88 REST OF EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 97
TABLE 89 REST OF EUROPE: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 97
9.4 ASIA PACIFIC 97
9.4.1 ASIA PACIFIC: RECESSION IMPACT 97
FIGURE 21 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET 98
TABLE 90 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY COUNTRY, 2021-2028 (USD MILLION) 99
TABLE 91 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 99
TABLE 92 ASIA PACIFIC: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 99
TABLE 93 ASIA PACIFIC: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 100
TABLE 94 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 100
TABLE 95 ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 100
9.4.2 JAPAN 101
9.4.2.1 Japan to hold largest market share throughout forecast period 101
TABLE 96 JAPAN: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 101
TABLE 97 JAPAN: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 101
TABLE 98 JAPAN: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 102
TABLE 99 JAPAN: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 102
TABLE 100 JAPAN: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 102
9.4.3 CHINA 103
9.4.3.1 China to register highest growth in APAC market 103
TABLE 101 CHINA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 103
TABLE 102 CHINA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 103
TABLE 103 CHINA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 104
TABLE 104 CHINA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 104
TABLE 105 CHINA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 104
9.4.4 INDIA 105
9.4.4.1 Rising number of hospitals and developing healthcare infrastructure to propel market growth 105
TABLE 106 INDIA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 105
TABLE 107 INDIA: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 105
TABLE 108 INDIA: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 106
TABLE 109 INDIA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 106
TABLE 110 INDIA: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 106
9.4.5 REST OF ASIA PACIFIC 107
TABLE 111 REST OF ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 107
TABLE 112 REST OF ASIA PACIFIC: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 107
TABLE 113 REST OF ASIA PACIFIC: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 108
TABLE 114 REST OF ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 108
TABLE 115 REST OF ASIA PACIFIC: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 108
9.5 REST OF THE WORLD 109
9.5.1 REST OF THE WORLD: RECESSION IMPACT 109
TABLE 116 REST OF THE WORLD: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TREATMENT MODALITY, 2021-2028 (USD MILLION) 110
TABLE 117 REST OF THE WORLD: CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 110
TABLE 118 REST OF THE WORLD: NON-CELL-BASED CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY TYPE, 2021-2028 (USD MILLION) 110
TABLE 119 REST OF THE WORLD: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION, 2021-2028 (USD MILLION) 111
TABLE 120 REST OF THE WORLD: CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET, BY APPLICATION SITE, 2021-2028 (USD MILLION) 111
?
10 COMPETITIVE LANDSCAPE 112
10.1 INTRODUCTION 112
10.2 REVENUE ANALYSIS 112
FIGURE 22 TOP FIVE PLAYERS HAVE DOMINATED MARKET IN LAST FIVE YEARS 112
10.3 MARKET SHARE ANALYSIS 113
FIGURE 23 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: MARKET SHARE ANALYSIS, 2022 113
TABLE 121 CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: DEGREE OF COMPETITION 113
10.4 COMPANY EVALUATION MATRIX 114
10.4.1 STARS 115
10.4.2 EMERGING LEADERS 115
10.4.3 PERVASIVE PLAYERS 115
10.4.4 PARTICIPANTS 115
FIGURE 24 GLOBAL CARTILAGE REPAIR/CARTILAGE REGENERATION MARKET: COMPANY EVALUATION MATRIX, 2022 116
10.5 COMPETITIVE SCENARIO 117
10.5.1 PRODUCT APPROVALS 117
TABLE 122 KEY PRODUCT APPROVALS, JANUARY 2020-NOVEMBER 2023 117
10.5.2 DEALS 117
TABLE 123 KEY DEALS, JANUARY 2020-NOVEMBER 2023 117
10.5.3 OTHER DEVELOPMENTS 118
TABLE 124 OTHER KEY DEVELOPMENTS, JANUARY 2020-NOVEMBER 2023 118
11 COMPANY PROFILES 119
11.1 KEY COMPANIES 119
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 SMITH+NEPHEW 119
TABLE 125 SMITH+NEPHEW: COMPANY OVERVIEW 119
FIGURE 25 SMITH+NEPHEW: COMPANY SNAPSHOT (2022) 120
11.1.2 DEPUY SYNTHES (JOHNSON & JOHNSON) 123
TABLE 126 JOHNSON & JOHNSON: COMPANY OVERVIEW 123
FIGURE 26 JOHNSON & JOHNSON: COMPANY SNAPSHOT (2022) 124
11.1.3 ZIMMER BIOMET HOLDINGS, INC. 127
TABLE 127 ZIMMER BIOMET HOLDINGS, INC.: COMPANY OVERVIEW 127
FIGURE 27 ZIMMER BIOMET HOLDINGS, INC.: COMPANY SNAPSHOT (2022) 128
11.1.4 STRYKER CORPORATION 131
TABLE 128 STRYKER CORPORATION: COMPANY OVERVIEW 131
FIGURE 28 STRYKER CORPORATION: COMPANY SNAPSHOT (2022) 132
11.1.5 VERICEL CORPORATION 134
TABLE 129 VERICEL CORPORATION: COMPANY OVERVIEW 134
FIGURE 29 VERICEL CORPORATION: COMPANY SNAPSHOT (2022) 134
11.1.6 B. BRAUN MELSUNGEN AG 136
TABLE 130 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 136
FIGURE 30 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2022) 137
11.1.7 ANIKA THERAPEUTICS, INC. 138
TABLE 131 ANIKA THERAPEUTICS, INC.: COMPANY OVERVIEW 138
FIGURE 31 ANIKA THERAPEUTICS, INC: COMPANY SNAPSHOT (2022) 139
11.1.8 RTI SURGICAL 140
TABLE 132 RTI SURGICAL: COMPANY OVERVIEW 140
11.1.9 CONMED CORPORATION 142
TABLE 133 CONMED CORPORATION.: COMPANY OVERVIEW 142
FIGURE 32 CONMED CORPORATION: COMPANY SNAPSHOT (2022) 143
11.1.10 ARTHREX INC. 145
TABLE 134 ARTHREX INC.: COMPANY OVERVIEW 145
11.1.11 REGROW BIOSCIENCES 146
TABLE 135 REGROW BIOSCIENCES: COMPANY OVERVIEW 146
11.1.12 MEDIPOST 147
TABLE 136 MEDIPOST: COMPANY OVERVIEW 147
FIGURE 33 MEDIPOST: COMPANY SNAPSHOT (2022) 147
11.2 OTHER PLAYERS 150
11.2.1 GEISTLICH PHARMA AG 150
11.2.2 ALLOSOURCE 150
11.2.3 ORTHOCELL LTD. 151
11.2.4 CARTIHEAL, INC. 151
11.2.5 REGENTIS BIOMATERIALS 152
11.2.6 LIFENET HEALTH 152
11.2.7 MATRICEL GMBH 153
11.2.8 THERACELL ADVANCED BIOTECHNOLOGY 153
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX 154
12.1 DISCUSSION GUIDE 154
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS SUBSCRIPTION PORTAL 157
12.3 CUSTOMIZATION OPTIONS 159
12.4 RELATED REPORTS 159
12.5 AUTHOR DETAILS 160
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security